Medications
(HealthDay)—For high-risk stage 1 nonseminoma germ cell tumors of the testis (NSGCTT), one cycle of adjuvant bleomycin, etoposide (500 mg/m²), and cisplatin (BE500P) is safe, resulting in a
Read More
Health News
TUESDAY, Aug. 7, 2018 — Overtreatment of thyroid cancers is common, according to a perspective article published in the July 25 issue of the New England Journal of
Read More